1 Moller, D. E. & Kaufman, K. D. Metabolic syndrome: a clinical and molecular perspective. Annual review of medicine 56, 45-62, doi:10.1146/annurev.med.56.082103.104751 (2005).
2 Brandhorst, S. et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration, Enhanced Cognitive Performance, and Healthspan. Cell Metab 22, 86-99, doi:10.1016/j.cmet.2015.05.012 (2015).
3 Fontana, L., Meyer, T. E., Klein, S. & Holloszy, J. O. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 101, 6659-6663, doi:10.1073/pnas.0308291101 (2004).
4 Longo, V. D. & Mattson, M. P. Fasting: molecular mechanisms and clinical applications. Cell Metab 19, 181-192, doi:10.1016/j.cmet.2013.12.008 (2014).
5 Geisler, C. E., Hepler, C., Higgins, M. R. & Renquist, B. J. Hepatic adaptations to maintain metabolic homeostasis in response to fasting and refeeding in mice. Nutr Metab (Lond) 13, 62, doi:10.1186/s12986-016-0122-x (2016).
6 Jordan, S. et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell 178, 1102-1114 e1117, doi:10.1016/j.cell.2019.07.050 (2019).
7 Glass, Christopher K. & Olefsky, Jerrold M. Inflammation and Lipid Signaling in the Etiology of Insulin Resistance. Cell Metabolism 15, 635-645, doi:http://dx.doi.org/10.1016/j.cmet.2012.04.001 (2012).
8 Lumeng, C. N. & Saltiel, A. R. Inflammatory links between obesity and metabolic disease. J. Clin. Invest. 121, 2111-2117, doi:10.1172/jci57132 (2011).
9 Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480-484, doi:10.1038/nature07540 (2009).
10 Thaiss, C. A., Zmora, N., Levy, M. & Elinav, E. The microbiome and innate immunity. Nature 535, 65-74, doi:10.1038/nature18847 (2016).
11 Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031, doi:10.1038/nature05414 (2006).
12 Mattson, M. P., Longo, V. D. & Harvie, M. Impact of intermittent fasting on health and disease processes. Ageing research reviews 39, 46-58, doi:10.1016/j.arr.2016.10.005 (2017).
13 Templeman, I., Gonzalez, J. T., Thompson, D. & Betts, J. A. The role of intermittent fasting and meal timing in weight management and metabolic health. The Proceedings of the Nutrition Society, 1-12, doi:10.1017/S0029665119000636 (2019).
14 Zhang, L. et al. Effects of Gliadin consumption on the Intestinal Microbiota and Metabolic Homeostasis in Mice Fed a High-fat Diet. Scientific reports 7, 44613, doi:10.1038/srep44613 (2017).
15 Zhao, G., Nyman, M. & Jonsson, J. A. Rapid determination of short-chain fatty acids in colonic contents and faeces of humans and rats by acidified water-extraction and direct-injection gas chromatography. Biomedical chromatography : BMC 20, 674-682, doi:10.1002/bmc.580 (2006).
16 Nejrup, R. G. et al. Lipid hydrolysis products affect the composition of infant gut microbial communities in vitro. The British journal of nutrition 114, 63-74, doi:10.1017/S0007114515000811 (2015).
17 Pedersen, M. H., Lauritzen, L. & Hellgren, L. I. Fish oil combined with SCFA synergistically prevent tissue accumulation of NEFA during weight loss in obese mice. The British journal of nutrition 106, 1449-1456, doi:10.1017/S0007114511001917 (2011).
18 Want, E. J. et al. Global metabolic profiling procedures for urine using UPLC-MS. Nature protocols 5, 1005-1018, doi:10.1038/nprot.2010.50 (2010).
19 Smith, C. A., Want, E. J., O'Maille, G., Abagyan, R. & Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Analytical chemistry 78, 779-787, doi:10.1021/ac051437y (2006).
20 Smith, C. A. et al. METLIN: a metabolite mass spectral database. Therapeutic drug monitoring 27, 747-751, doi:10.1097/01.ftd.0000179845.53213.39 (2005).
21 Wishart, D. S. et al. HMDB 3.0--The Human Metabolome Database in 2013. Nucleic acids research 41, D801-807, doi:10.1093/nar/gks1065 (2013).
22 Jari Oksanen, F. G. B., Michael Friendly, Roeland Kindt, Pierre Legendre, Dan McGlinn, Peter R. Minchin, R. B. O'Hara, Gavin L. Simpson, Peter Solymos, M. Henry H. Stevens, Eduard Szoecs and Helene Wagner. vegan: Community Ecology Package. R package version 2.5-3. https://CRAN.R-project.org/package=vegan (2018).
23 R_Core_Team. R: A language and environment for statistical computing. https://www.R-project.org/. (2015).
24 Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics 9, 559, doi:10.1186/1471-2105-9-559 (2008).
25 Payne, A. N., Chassard, C., Banz, Y. & Lacroix, C. The composition and metabolic activity of child gut microbiota demonstrate differential adaptation to varied nutrient loads in an in vitro model of colonic fermentation. Fems Microbiol Ecol 80, 608-623, doi:10.1111/j.1574-6941.2012.01330.x (2012).
26 Lu, Y. et al. Short Chain Fatty Acids Prevent High-fat-diet-induced Obesity in Mice by Regulating G Protein-coupled Receptors and Gut Microbiota. Scientific reports 6, 37589, doi:10.1038/srep37589 (2016).
27 Gao, Z. et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517, doi:10.2337/db08-1637 (2009).
28 Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242-+, doi:10.1038/nature14115 (2015).
29 Linhart, H. G. et al. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci U S A 98, 12532-12537, doi:10.1073/pnas.211416898 (2001).
30 Morrison, D. J. & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut microbes 7, 189-200, doi:10.1080/19490976.2015.1134082 (2016).
31 Lewis, S. J. & Heaton, K. W. Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 41, 245-251, doi:10.1136/gut.41.2.245 (1997).
32 Macfarlane, S., Quigley, M. E., Hopkins, M. J., Newton, D. F. & Macfarlane, G. T. Polysaccharide degradation by human intestinal bacteria during growth under multi-substrate limiting conditions in a three-stage continuous culture system. Fems Microbiol Ecol 26, 231-243, doi:DOI 10.1111/j.1574-6941.1998.tb00508.x (1998).
33 Sonnenburg, J. L. & Backhed, F. Diet-microbiota interactions as moderators of human metabolism. Nature 535, 56-64, doi:10.1038/nature18846 (2016).
34 Kelly, C. J. et al. Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe 17, 662-671, doi:10.1016/j.chom.2015.03.005 (2015).
35 Vieira, E. L. et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem 23, 430-436, doi:10.1016/j.jnutbio.2011.01.007 (2012).
36 Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60, doi:10.1038/nature11450 (2012).
37 den Besten, G. et al. Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARgamma-Dependent Switch From Lipogenesis to Fat Oxidation. Diabetes 64, 2398-2408, doi:10.2337/db14-1213 (2015).
38 Wang, X. et al. Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway. Scientific reports 5, 12676, doi:10.1038/srep12676 (2015).
39 Lee, M. W. et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160, 74-87, doi:10.1016/j.cell.2014.12.011 (2015).
40 Brestoff, J. R. & Artis, D. Immune regulation of metabolic homeostasis in health and disease. Cell 161, 146-160, doi:10.1016/j.cell.2015.02.022 (2015).
41 Fabbiano, S. et al. Caloric Restriction Leads to Browning of White Adipose Tissue through Type 2 Immune Signaling. Cell Metab 24, 434-446, doi:10.1016/j.cmet.2016.07.023 (2016).
42 Li, G. et al. Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota. Cell Metab 26, 801, doi:10.1016/j.cmet.2017.10.007 (2017).
43 Monticelli, L. A. et al. IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions. Proc Natl Acad Sci U S A 112, 10762-10767, doi:10.1073/pnas.1509070112 (2015).
44 Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. The Journal of experimental medicine 210, 535-549, doi:10.1084/jem.20121964 (2013).
45 Herbert, D. R. et al. Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. The Journal of experimental medicine 206, 2947-2957, doi:10.1084/jem.20091268 (2009).
46 McKenzie, G. J., Bancroft, A., Grencis, R. K. & McKenzie, A. N. A distinct role for interleukin-13 in Th2-cell-mediated immune responses. Current biology : CB 8, 339-342 (1998).
47 Schiering, C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568, doi:10.1038/nature13577 (2014).
48 Vasanthakumar, A. et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol 16, 276-285, doi:10.1038/ni.3085 (2015).
49 Yang, Z. et al. IL-33-induced alterations in murine intestinal function and cytokine responses are MyD88, STAT6, and IL-13 dependent. American journal of physiology. Gastrointestinal and liver physiology 304, G381-389, doi:10.1152/ajpgi.00357.2012 (2013).
50 Cayrol, C. & Girard, J. P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 106, 9021-9026, doi:10.1073/pnas.0812690106 (2009).
51 Youm, Y. H. et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nature medicine 21, 263-269, doi:10.1038/nm.3804 (2015).
52 Traba, J. et al. Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects. J Clin Invest 125, 4592-4600, doi:10.1172/JCI83260 (2015).
53 Preidis, G. A., Kim, K. H. & Moore, D. D. Nutrient-sensing nuclear receptors PPARalpha and FXR control liver energy balance. J Clin Invest 127, 1193-1201, doi:10.1172/JCI88893 (2017).
54 Grabacka, M., Pierzchalska, M., Dean, M. & Reiss, K. Regulation of Ketone Body Metabolism and the Role of PPARalpha. Int J Mol Sci 17, doi:10.3390/ijms17122093 (2016).
55 Kersten, S. et al. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103, 1489-1498, doi:10.1172/JCI6223 (1999).
56 Zhang, C. et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nature communications 4, 2163, doi:10.1038/ncomms3163 (2013).
57 Duszka, K. et al. Complementary intestinal mucosa and microbiota responses to caloric restriction. Scientific reports 8, 11338, doi:10.1038/s41598-018-29815-7 (2018).
58 Pedersen, H. K. et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535, 376-381, doi:10.1038/nature18646 (2016).
59 Kim, K. H. et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell research 27, 1309-1326, doi:10.1038/cr.2017.126 (2017).